WEEXA BIOLOGICALS

Active

Private limited companyfounded 20223 yrs activeRue Strivay(PLX) 67, 4122 Neupré, BelgiumKBO/BCE: BE 0791.956.795

WEEXA BIOLOGICALS has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €88k and a net result of €-35k. Equity is growing by ~33.3% per year across the filed fiscal years. Its solvency ranks better than 46% of 115 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Watch Print / PDF

Checked score

Score 2025

7 / 100

Critical▼ -93 vs 2024

The score combines four axes. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability0▼-100

Solvency32▼-67

Growth52▼-26

Stability94

Bankruptcy probability, 12 months

1.0% Low

0%0.5%1.5%4%10%≥ 25%

No credit on open account

Liquidity short (current ratio 0.91 against 2.84 in 2024), and 76.3% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 20

Relative position

BE, all sectors

reference

Sector 20

lower

← fewer bankruptcies more bankruptcies →

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

23.7%

Return on assets

-9.3%

Age of the figures

8 mo

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 3 filings

Deviation from the deadline

2025

28 d late

2024

37 d early

2023

6 d early

← before the deadline after the deadline →

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

15-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity

€88k▼ 26.8%

2024 · €121k

2023: €29k 2024: €121k

2023 → 2025

Total assets

€372k▲ 92.9%

2024 · €193k

2023: €88k 2024: €193k

2023 → 2025

Net result

€-35k

2024 · €49k

2023: €19k 2024: €49k

2023 → 2025

Working capital

€-16k

2024 · €89k

2023: €54k 2024: €89k

2023 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line202320242025Trend

Equity€29k-€121k▲ 309%€88k▼ 26.8%

Operating result€24k-€59k▲ 145%€-40k

Net result€19k-€49k▲ 152%€-35k

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result turns negative in 2025: a loss of €40k after €59k in 2024, the lowest year so far.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €372k

54.3%

45.7%

Fixed assets €202k▲ 260%

Current assets €170k▲ 24.2%

Equity and liabilities €372k

23.7%

76.3%

Equity €88k▼ 26.8%

Debt €284k▲ 293%

The debt ratio rises from 37.5% to 76.3%: debt grows while equity shrinks.

Key figures and ratios

2025 value · change against 2024

EBITDA

€-5k▼

2024 · €65k

Cash flow

€31▼

2024 · €54k

Solvency

23.7%▼

2024 · 62.5%

Current ratio

0.91▼

2024 · 2.84

Quick ratio

0.88▼

2024 · 2.58

Debt / equity

3.21▲

2024 · 0.60

ROE

-39.1%▼

2024 · 40.7%

ROA

-9.3%▼

2024 · 25.5%

Interest coverage

-32.77▼

2024 · 209.06

Debt

€284k▲

2024 · €72k

Debt ≤ 1 year

€186k▲

2024 · €48k

Debt > 1 year

€75k

Income taxes

€4k▼

2024 · €12k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2025 against 2024

Balance sheet Code20242025

Assets

Total assets20/58€193k€372k▲

Fixed assets21/28€56k€202k▲

Intangible fixed assets21€53k€200k▲

Tangible fixed assets22/27€3k€2k▼

Furniture and vehicles24€3k€2k▼

Current assets29/58€137k€170k▲

Stocks and contracts in progress3€13k€6k▼

Stocks30/36€13k€6k▼

Amounts receivable within one year40/41€28k€35k▲

Trade receivables40€19k€28k▲

Other amounts receivable41€9k€7k▼

Cash at bank and in hand54/58€96k€117k▲

Deferred charges and accrued income490/1-€12k

Equity and liabilities

Total equity and liabilities10/49€193k€372k▲

Equity10/15€121k€88k▼

Contributions10/11€10k€10k=

Reserves13€69k€34k▼

Distributable reserves133€69k€34k▼

Investment grants15€42k€44k▲

Amounts payable17/49€72k€284k▲

Amounts payable after more than one year17-€75k

Financial debts170/4-€75k

Amounts payable within one year42/48€48k€186k▲

Financial debts43€159€0▼

Credit institutions430/8€159€0▼

Trade debts44€36k€162k▲

Suppliers440/4€36k€162k▲

Taxes, remuneration and social security45€2k€0▼

Taxes450/3€2k€0▼

Other amounts payable47/48€10k€24k▲

Accrued charges and deferred income492/3€24k€23k▼

Income statement Code20242025

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€35k▲

Other operating charges640/8€387€400▲

Gross operating margin9900€65k€-5k▼

Operating profit (loss)9901€59k€-40k▼

Financial income75/76B€2k€9k▲

Recurring financial income75€2k€9k▲

Financial charges65/66B€309€158▼

Recurring financial charges65€309€158▼

Profit (loss) for the period before taxes9903€61k€-30k▼

Income taxes67/77€12k€4k▼

Profit (loss) for the period9904€49k€-35k▼

Profit (loss) for the period to be appropriated9905€49k€-35k▼

Appropriation of the result

Profit (loss) to be appropriated9906€49k€-35k▼

Transfer from equity791/2-€69k

Transfer to equity691/2€49k€34k▼

To other reserves6921€49k€34k▼

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 6Financial 3Filings 3

Next filing, fiscal year 2026, expected by 31-07-2027

2026

28-08

NBB filing Annual accounts filed

fiscal year 2025 · micro schema · 28 days late

2025

31-12

Financial Weakest financial yearnet €-35k ▼170%

Net result drops to €-35k, the lowest in the series.

24-06

NBB filing Annual accounts filed

fiscal year 2024 · micro schema

2024

31-12

Financial Highest result since 2023net €49k ▲152%

Operating result €59k, net result €49k, both a record.

31-12

Financial Equity above €100kEq €121k ▲309%

2 profitable years in a row build equity to €121k.

25-07

NBB filing Annual accounts filed

fiscal year 2023 · micro schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Neupré · 1 establishment unit since 2022

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Strivay(PLX) 674122 Neupré

Ground area

571 m²

Building footprint

161 m²

Volume, LiDAR

1,011 m³

Parcel 62081C0364/00D000, Wallonia · tallest building 8.5 m, ±2 floors. Linked by address, not a title deed.

1 establishment unit

Rue Haie Nicolas 42, 5030 Gembloux

Manufacture of chemicals and chemical products

since 20222.336.888.069

1 parcel

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
62081C0364/00D000	Wallonia	571 m²	1 · 160 m²	8.5 m · 2 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site

Gembloux2.336.888.069

1 permission

Groothandelaar meststoffen · since 01-09-2023

Similar companies · same sector, comparable size

SBAM

BE 0599.901.349

Waterloo · Eq €91k

Duurzaam Rotsvast Vertrouwen

Hoogstraten · Eq €102k

Of 76 companies in sector 20150 we hold annual accounts for 63. 21 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded06-10-2022

Fiscal year end31-12

Abbreviation FR WEEXA

Activities, NACEBEL

20150Manufacture of chemicals and chemical products

20200Manufacture of chemicals and chemical products

46214Wholesale trade

46852Wholesale trade

70200Business and other management consultancy

70220Business consulting

72101Research and development on biotechnology

Sources

Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry

E-mail:f.weekers@fwbioconsult.be

Establishment Gembloux 2.336.888.069